Groundbreaking neurostimulation technology offers hope and healing for difficult-to-manage pain. Chronic low back pain, a formidable foe causing disability and soaring healthcare costs, now faces a ...

The novel design of a deep muscle along the spinal column called the multifidus muscle may in fact be key to spinal support and a healthy back, according to researchers. Their findings about the ...

Please provide your email address to receive an email when new articles are posted on . Results published in Orthopedics showed facet joint osteoarthritis was associated with a higher multifidus ...

Physicians at the UAB Pain Treatment Clinic are offering a new treatment for chronic low back pain. The treatment focuses on stimulating one of the key stabilizing muscles of the lumbar spine, the ...

Background The high prevalence of non-specific low back pain and its correlation with the findings in the lumbar multifidus muscles (electromyography activity, morphology and thickness) and good ...

Background In Australian Football, hip, groin and thigh (HGT) muscle injuries have had the highest incidence and prevalence. A previous study showed that football players with relatively more severe ...

The four main muscles of the deep core—transverse abdominis, multifidus, pelvic floor and the diaphragm—work together to keep ...

Editor's note: This article is part of TheHorse.com's ongoing coverage of topics presented at the 2012 International Society of Equitation Science conference, held July 18-20 in Edinburgh, Scotland.

Mainstay Medical Holdings plc today announced that the International Society for the Advancement of Spine Surgery (ISASS) has issued recommendations and coverage criteria for the use of restorative ...

DUBLIN--(BUSINESS WIRE)--Mainstay Medical today announced that the United States Centers for Disease Control and Prevention (CDC) has designated an International Classification of Diseases, Tenth ...

Mainstay Medical Holdings plc has won U.S. FDA approval for its Reactiv8 implantable neurostimulation device. The company is eyeing a commercial launch of the system in early 2021. The FDA approved ...